Your browser doesn't support javascript.
loading
Hsa_circ_0102171 aggravates the progression of cervical cancer through targeting miR-4465/CREBRF axis.
Tang, Xi; Wen, Xiaomin; Li, Zhouyu; Wen, Danxia; Lin, Ling; Liu, Jinquan; Li, Mingyi.
Afiliação
  • Tang X; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wen X; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Li Z; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wen D; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Lin L; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Liu J; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Li M; The 5th Ward of Radiotherapy Department of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
J Cell Physiol ; 236(7): 4973-4984, 2021 07.
Article em En | MEDLINE | ID: mdl-33615474

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Neoplasias do Colo do Útero / Proteínas Supressoras de Tumor / MicroRNAs / RNA Circular Limite: Animals / Female / Humans Idioma: En Revista: J Cell Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Neoplasias do Colo do Útero / Proteínas Supressoras de Tumor / MicroRNAs / RNA Circular Limite: Animals / Female / Humans Idioma: En Revista: J Cell Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China